Dr. Kahn is a Professor at the
Philip R. Lee
Institute for Health Policy Studies, the AIDS Research Institute, and the Department of Epidemiology and Biostatistics, all at UCSF. Dr. Kahn is an expert in policy modeling in health care, cost-effectiveness analysis, and evidence-based medicine. His work focuses on the use of cost-effectiveness analysis to inform decision-making in public health and medicine.
Dr. Kahn had done multiple studies of economic aspects of HIV prevention and care in low-income countries. He was the principal investigator for a study of the cost, outputs, impact, and cost-effectiveness of HIV prevention programs in five countries ( India, Mexico, South Africa, Uganda, and Russia). He has also done HIV economic studies in Tanzania and the Baltics.
Dr. Kahn’s policy research includes issues in the U.S. He was the principal investigator for HRSA-funded research on measuring unmet need for HIV primary medical care. He has conducted economic and access-to-care analyses of insurance and subsidy programs for AIDS care, drugs, and home health care, including expanding Medicaid to cover all individuals with HIV disease.
Dr. Kahn served on a National Academies of Science / Institute of Medicine Committee on the Public Financing and Delivery of HIV Care.
Dr. Kahn has estimated the magnitude and components of billing and insurance-related administrative costs in U.S. health care. He also conducts cost-effectiveness analyses in reproductive health (pregnancy and STD prevention) and other disease areas. He is the lead instructor in cost-effectiveness analysis in the medical school at UCSF.
Dr. Kahn is currently focusing on developing the capabilities at UCSF for collaborative work on global health economics and policy, and on policy issues in translating basic science findings into clinical research, and then into widespread clinical practice.
|
